Rockwell Medical Financials
RMTI Stock | USD 2.31 0.06 2.67% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.38 | 0.401 |
|
| |||||
Current Ratio | 2.62 | 1.7293 |
|
|
The essential information of the day-to-day investment outlook for Rockwell Medical includes many different criteria found on its balance sheet. An individual investor should monitor Rockwell Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Rockwell Medical.
Net Income |
|
Rockwell | Select Account or Indicator |
Understanding current and past Rockwell Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Rockwell Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Rockwell Medical's assets may result in an increase in income on the income statement.
Rockwell Medical Earnings Geography
Rockwell Medical Stock Summary
Rockwell Medical competes with Lifecore Biomedical, Kamada, Intracellular, Regencell Bioscience, and Procaps Group. Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Rockwell Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 300 people.Specialization | Health Care, Drug Manufacturers - Specialty & Generic |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US7743741024 |
CUSIP | 774374102 774374300 |
Location | New Jersey; U.S.A |
Business Address | 30142 South Wixom |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.rockwellmed.com |
Phone | 248 960 9009 |
Currency | USD - US Dollar |
Rockwell Medical Key Financial Ratios
Return On Equity | -0.29 | ||||
Profit Margin | (0.05) % | ||||
Operating Margin | 0.02 % | ||||
Price To Sales | 0.77 X | ||||
Revenue | 83.61 M |
Rockwell Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 44.3M | 77.7M | 48.6M | 46.6M | 52.2M | 37.3M | |
Other Current Liab | 4.8M | 5.3M | 5.2M | 7.8M | 9.9M | 10.4M | |
Net Debt | (7.8M) | (24.7M) | 15.6M | (5.1M) | 4.5M | 4.7M | |
Retained Earnings | (306.5M) | (337.4M) | (370.1M) | (388.8M) | (397.2M) | (377.3M) | |
Accounts Payable | 3.0M | 4.2M | 3.7M | 4.1M | 4.5M | 4.1M | |
Cash | 11.8M | 48.7M | 13.3M | 21.5M | 9.0M | 13.5M | |
Net Receivables | 4.2M | 4.2M | 5.9M | 6.3M | 10.9M | 11.4M | |
Inventory | 3.6M | 3.9M | 4.1M | 5.8M | 5.9M | 3.8M | |
Other Current Assets | 3.0M | 2.7M | 2.9M | 1.7M | 1.1M | 1.1M | |
Total Liab | 24.0M | 43.6M | 46.0M | 32.5M | 30.9M | 18.1M | |
Total Current Assets | 36.9M | 69.5M | 35.3M | 35.3M | 28.8M | 31.1M | |
Short Term Debt | 2.3M | 1.2M | 9.8M | 4.1M | 2.2M | 1.8M | |
Common Stock | 299.6M | 6.5K | 9K | 1K | 3K | 2.9K | |
Intangible Assets | 4.0K | 3.7K | 3.3K | 10.8M | 12.4M | 13.0M | |
Other Assets | 875.9K | 4.7M | 2.1M | 13.8M | 15.9M | 16.7M | |
Net Tangible Assets | 19.4M | 33.2M | 1.6M | 13.2M | 11.9M | 20.7M | |
Other Liab | 9.8M | 8.0M | 6M | 2.6M | 2.4M | 2.2M |
Rockwell Medical Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 61.3M | 62.2M | 61.9M | 72.8M | 83.6M | 45.6M | |
Gross Profit | 2.8M | 2.7M | (2.4M) | 4.1M | 8.7M | 9.1M | |
Operating Income | (34.1M) | (28.4M) | (30.3M) | (16.8M) | (6.7M) | (7.0M) | |
Ebit | (34.1M) | (29.0M) | (30.3M) | (18.8M) | (6.1M) | (6.4M) | |
Ebitda | (34.1M) | (26.7M) | (27.8M) | (16.2M) | (4.7M) | (4.9M) | |
Cost Of Revenue | 58.5M | 59.5M | 64.4M | 68.7M | 74.9M | 41.4M | |
Net Income | (31.1M) | (31.9M) | (35.0M) | (20.6M) | (8.4M) | (8.9M) | |
Income Tax Expense | (3.0M) | 1.0M | 2.4M | 1.9M | 1.3M | 1.3M | |
Income Before Tax | (34.1M) | (30.9M) | (32.7M) | (18.7M) | (8.4M) | (8.9M) | |
Research Development | 6.9M | 7.1M | 6.8M | 3.1M | 1.1M | 1.1M | |
Interest Income | 367.1K | 238K | 22K | 33K | 211K | 257.7K | |
Net Interest Income | 367.1K | (1.6M) | (2.3M) | (1.9M) | (1.4M) | (1.3M) |
Rockwell Medical Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (10.9M) | 36.9M | (35.4M) | (3.2M) | (1.1M) | (1.1M) | |
Free Cash Flow | (28.6M) | (30.7M) | (34.1M) | (17.7M) | (9.7M) | (10.2M) | |
Depreciation | 2.7M | 2.3M | 2.5M | 2.6M | 1.4M | 1.1M | |
Other Non Cash Items | 1.2M | 294K | 369K | 969K | 3.9M | 4.1M | |
Capital Expenditures | 1.3M | 1.0M | 522K | 281K | 284K | 269.8K | |
Net Income | (34.1M) | (30.9M) | (32.7M) | (18.7M) | (8.4M) | (8.9M) | |
End Period Cash Flow | 11.8M | 48.7M | 13.3M | 10.1M | 9.0M | 13.2M | |
Change To Inventory | 316.9K | (1.3M) | (656K) | (2.1M) | 1.2M | 1.2M | |
Investments | 38.3M | 4.3M | 311K | (2.4M) | (1.8M) | (1.7M) | |
Change To Netincome | 6.2M | 1.6M | 1.1M | 915K | 823.5K | 782.3K |
Rockwell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rockwell Medical's current stock value. Our valuation model uses many indicators to compare Rockwell Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rockwell Medical competition to find correlations between indicators driving Rockwell Medical's intrinsic value. More Info.Rockwell Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Rockwell Medical's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rockwell Medical's earnings, one of the primary drivers of an investment's value.Rockwell Medical's Earnings Breakdown by Geography
Rockwell Medical Systematic Risk
Rockwell Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Rockwell Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Rockwell Medical correlated with the market. If Beta is less than 0 Rockwell Medical generally moves in the opposite direction as compared to the market. If Rockwell Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Rockwell Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Rockwell Medical is generally in the same direction as the market. If Beta > 1 Rockwell Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Rockwell Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rockwell Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rockwell Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Rockwell Medical November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Rockwell Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rockwell Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rockwell Medical based on widely used predictive technical indicators. In general, we focus on analyzing Rockwell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rockwell Medical's daily price indicators and compare them against related drivers.
Information Ratio | (0.04) | |||
Maximum Drawdown | 57.6 | |||
Value At Risk | (7.07) | |||
Potential Upside | 8.18 |
Complementary Tools for Rockwell Stock analysis
When running Rockwell Medical's price analysis, check to measure Rockwell Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rockwell Medical is operating at the current time. Most of Rockwell Medical's value examination focuses on studying past and present price action to predict the probability of Rockwell Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rockwell Medical's price. Additionally, you may evaluate how the addition of Rockwell Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |